|Opens resource in a 2nd browser window.|
BioTime is engaged in the research and development of aqueous-based synthetic solutions that may be used as plasma expanders, organ preservation solutions, or solutions to replace blood volume during low temperature surgery.
“BioTransplant Incorporated, is
developing therapeutics based on its proprietary ImmunoCognance(tm) technology to re-educate the body’s immune system to accept transplanted cells, tissues and organs.”
Integra LifeSciences Corporation
Integra LifeSciences Corporation develops and supplies medical products for tissue regeneration.
OsteoBiologics, Inc. develops and manufactures bioabsorbable tissue-engineering scaffolds for the repair and replacement of musculoskeletal tissues.
Signature Immunologics produces anti-hapten IgG’s for high performance immunocytochemistry of tissue cultures, EM sections, and frozen sections.
Tissue Therapeutics, Inc.
The focus of the company is to apply the techniques of biochemical engineering to develop medically useful cellular products from human umbilical cord blood and other sources of stem cells.